Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 5188 entries
Sorted by: Best Match Show Resources per page
Workshop on Psychosocial Factors in Coronary Heart Disease. 23-25 April 1987, Dubrovnik, Yugoslavia. Proceedings.

European heart journal

[No authors listed]
PMID: 3409901
Eur Heart J. 1988 Jun;9(6):685-714.

No abstract available.

Cite
Workshop on Psychosocial Factors in Coronary Heart Disease. 23-25 April 1987, Dubrovnik, Yugoslavia. Proceedings. Eur Heart J. 1988;9(6):685-714
(1988). Workshop on Psychosocial Factors in Coronary Heart Disease. 23-25 April 1987, Dubrovnik, Yugoslavia. Proceedings. European heart journal, 9(6), 685-714.
"Workshop on Psychosocial Factors in Coronary Heart Disease. 23-25 April 1987, Dubrovnik, Yugoslavia. Proceedings." European heart journal vol. 9,6 (1988): 685-714.
Workshop on Psychosocial Factors in Coronary Heart Disease. 23-25 April 1987, Dubrovnik, Yugoslavia. Proceedings. Eur Heart J. 1988 Jun;9(6):685-714. PMID: 3409901.
Copy Download .nbib Format: NLM
How e-biking can boost cardiovascular health.

European heart journal

Gloekler S, Wenaweser P, Lanz J, Stoller M.
PMID: 25935878
Eur Heart J. 2015 Aug 14;36(31):2033. doi: 10.1093/eurheartj/ehv154. Epub 2015 May 01.

No abstract available.

Cite
Gloekler S, Wenaweser P, Lanz J, et al. How e-biking can boost cardiovascular health. Eur Heart J. 2015;36(31):2033doi: 10.1093/eurheartj/ehv154.
Gloekler, S., Wenaweser, P., Lanz, J., & Stoller, M. (2015). How e-biking can boost cardiovascular health. European heart journal, 36(31), 2033. https://doi.org/10.1093/eurheartj/ehv154
Gloekler, Steffen, et al. "How e-biking can boost cardiovascular health." European heart journal vol. 36,31 (2015): 2033. doi: https://doi.org/10.1093/eurheartj/ehv154
Gloekler S, Wenaweser P, Lanz J, Stoller M. How e-biking can boost cardiovascular health. Eur Heart J. 2015 Aug 14;36(31):2033. doi: 10.1093/eurheartj/ehv154. Epub 2015 May 01. PMID: 25935878.
Copy Download .nbib Format: NLM
Targeting inflammatory pathways for the treatment of cardiovascular disease.

European heart journal

Ridker PM.
PMID: 24204011
Eur Heart J. 2014 Mar;35(9):540-3. doi: 10.1093/eurheartj/eht398. Epub 2013 Nov 07.

No abstract available.

Cite
Ridker PM. Targeting inflammatory pathways for the treatment of cardiovascular disease. Eur Heart J. 2013;35(9):540-3doi: 10.1093/eurheartj/eht398.
Ridker, P. M. (2014). Targeting inflammatory pathways for the treatment of cardiovascular disease. European heart journal, 35(9), 540-3. https://doi.org/10.1093/eurheartj/eht398
Ridker, Paul M. "Targeting inflammatory pathways for the treatment of cardiovascular disease." European heart journal vol. 35,9 (2014): 540-3. doi: https://doi.org/10.1093/eurheartj/eht398
Ridker PM. Targeting inflammatory pathways for the treatment of cardiovascular disease. Eur Heart J. 2014 Mar;35(9):540-3. doi: 10.1093/eurheartj/eht398. Epub 2013 Nov 07. PMID: 24204011; PMCID: PMC3954097.
Copy Download .nbib Format: NLM
Risks in estimating risk.

European heart journal

Graham IM, Cooney MT.
PMID: 24204012
Eur Heart J. 2014 Mar;35(9):537-9. doi: 10.1093/eurheartj/eht286. Epub 2013 Nov 07.

No abstract available.

Cite
Graham IM, Cooney MT. Risks in estimating risk. Eur Heart J. 2013;35(9):537-9doi: 10.1093/eurheartj/eht286.
Graham, I. M., & Cooney, M. T. (2014). Risks in estimating risk. European heart journal, 35(9), 537-9. https://doi.org/10.1093/eurheartj/eht286
Graham, Ian M, and Cooney, Marie-Therese. "Risks in estimating risk." European heart journal vol. 35,9 (2014): 537-9. doi: https://doi.org/10.1093/eurheartj/eht286
Graham IM, Cooney MT. Risks in estimating risk. Eur Heart J. 2014 Mar;35(9):537-9. doi: 10.1093/eurheartj/eht286. Epub 2013 Nov 07. PMID: 24204012.
Copy Download .nbib Format: NLM
The search for a new assay of myocardial necrosis.

European heart journal

Nicholls M.
PMID: 28911193
Eur Heart J. 2017 Sep 07;38(34):2577-2578. doi: 10.1093/eurheartj/ehx440.

No abstract available.

Cite
Nicholls M. The search for a new assay of myocardial necrosis. Eur Heart J. 2017;38(34):2577-2578doi: 10.1093/eurheartj/ehx440.
Nicholls, M. (2017). The search for a new assay of myocardial necrosis. European heart journal, 38(34), 2577-2578. https://doi.org/10.1093/eurheartj/ehx440
Nicholls, Mark. "The search for a new assay of myocardial necrosis." European heart journal vol. 38,34 (2017): 2577-2578. doi: https://doi.org/10.1093/eurheartj/ehx440
Nicholls M. The search for a new assay of myocardial necrosis. Eur Heart J. 2017 Sep 07;38(34):2577-2578. doi: 10.1093/eurheartj/ehx440. PMID: 28911193.
Copy Download .nbib Format: NLM
Cindy L Grines MD FACC SCAI.

European heart journal

Ozkan J.
PMID: 28938725
Eur Heart J. 2017 Mar 07;38(10):700-701. doi: 10.1093/eurheartj/ehx059.

No abstract available.

Cite
Ozkan J. Cindy L Grines MD FACC SCAI. Eur Heart J. 2017;38(10):700-701doi: 10.1093/eurheartj/ehx059.
Ozkan, J. (2017). Cindy L Grines MD FACC SCAI. European heart journal, 38(10), 700-701. https://doi.org/10.1093/eurheartj/ehx059
Ozkan, Judy. "Cindy L Grines MD FACC SCAI." European heart journal vol. 38,10 (2017): 700-701. doi: https://doi.org/10.1093/eurheartj/ehx059
Ozkan J. Cindy L Grines MD FACC SCAI. Eur Heart J. 2017 Mar 07;38(10):700-701. doi: 10.1093/eurheartj/ehx059. PMID: 28938725.
Copy Download .nbib Format: NLM
Fractional Flow ReserveCT (FFRCT).

European heart journal

Fairbairn TA.
PMID: 28863462
Eur Heart J. 2017 Jun 21;38(24):1867-1869. doi: 10.1093/eurheartj/ehx285.

No abstract available.

Cite
Fairbairn TA. Fractional Flow ReserveCT (FFRCT). Eur Heart J. 2017;38(24):1867-1869doi: 10.1093/eurheartj/ehx285.
Fairbairn, T. A. (2017). Fractional Flow ReserveCT (FFRCT). European heart journal, 38(24), 1867-1869. https://doi.org/10.1093/eurheartj/ehx285
Fairbairn, Timothy A. "Fractional Flow ReserveCT (FFRCT)." European heart journal vol. 38,24 (2017): 1867-1869. doi: https://doi.org/10.1093/eurheartj/ehx285
Fairbairn TA. Fractional Flow ReserveCT (FFRCT). Eur Heart J. 2017 Jun 21;38(24):1867-1869. doi: 10.1093/eurheartj/ehx285. PMID: 28863462.
Copy Download .nbib Format: NLM
WHF Emerging Leaders Program.

European heart journal

Huffman MD, Perel P, Eisele JL, Labarthe DR, Wood DA, Sliwa K, Yusuf S.
PMID: 28982234
Eur Heart J. 2017 Oct 01;38(37):2800-2803. doi: 10.1093/eurheartj/ehx483.

No abstract available.

Cite
Huffman MD, Perel P, Eisele JL, et al. WHF Emerging Leaders Program. Eur Heart J. 2017;38(37):2800-2803doi: 10.1093/eurheartj/ehx483.
Huffman, M. D., Perel, P., Eisele, J. L., Labarthe, D. R., Wood, D. A., Sliwa, K., & Yusuf, S. (2017). WHF Emerging Leaders Program. European heart journal, 38(37), 2800-2803. https://doi.org/10.1093/eurheartj/ehx483
Huffman, Mark D, et al. "WHF Emerging Leaders Program." European heart journal vol. 38,37 (2017): 2800-2803. doi: https://doi.org/10.1093/eurheartj/ehx483
Huffman MD, Perel P, Eisele JL, Labarthe DR, Wood DA, Sliwa K, Yusuf S. WHF Emerging Leaders Program. Eur Heart J. 2017 Oct 01;38(37):2800-2803. doi: 10.1093/eurheartj/ehx483. PMID: 28982234.
Copy Download .nbib Format: NLM
From bench to bedside: the clinical future on the horizon of experimental evidence.

European heart journal

Lüscher TF.
PMID: 28482044
Eur Heart J. 2017 May 07;38(18):1351-1354. doi: 10.1093/eurheartj/ehx207.

No abstract available.

Cite
Lüscher TF. From bench to bedside: the clinical future on the horizon of experimental evidence. Eur Heart J. 2017;38(18):1351-1354doi: 10.1093/eurheartj/ehx207.
Lüscher, T. F. (2017). From bench to bedside: the clinical future on the horizon of experimental evidence. European heart journal, 38(18), 1351-1354. https://doi.org/10.1093/eurheartj/ehx207
Lüscher, Thomas F. "From bench to bedside: the clinical future on the horizon of experimental evidence." European heart journal vol. 38,18 (2017): 1351-1354. doi: https://doi.org/10.1093/eurheartj/ehx207
Lüscher TF. From bench to bedside: the clinical future on the horizon of experimental evidence. Eur Heart J. 2017 May 07;38(18):1351-1354. doi: 10.1093/eurheartj/ehx207. PMID: 28482044.
Copy Download .nbib Format: NLM
Gender issues in arrhythmias: from atrial fibrillation to CRT and arrhythmogenic ventricular cardiomyopathy.

European heart journal

Lüscher TF.
PMID: 28510712
Eur Heart J. 2017 May 14;38(19):1443-1446. doi: 10.1093/eurheartj/ehx216.

No abstract available.

Cite
Lüscher TF. Gender issues in arrhythmias: from atrial fibrillation to CRT and arrhythmogenic ventricular cardiomyopathy. Eur Heart J. 2017;38(19):1443-1446doi: 10.1093/eurheartj/ehx216.
Lüscher, T. F. (2017). Gender issues in arrhythmias: from atrial fibrillation to CRT and arrhythmogenic ventricular cardiomyopathy. European heart journal, 38(19), 1443-1446. https://doi.org/10.1093/eurheartj/ehx216
Lüscher, Thomas F. "Gender issues in arrhythmias: from atrial fibrillation to CRT and arrhythmogenic ventricular cardiomyopathy." European heart journal vol. 38,19 (2017): 1443-1446. doi: https://doi.org/10.1093/eurheartj/ehx216
Lüscher TF. Gender issues in arrhythmias: from atrial fibrillation to CRT and arrhythmogenic ventricular cardiomyopathy. Eur Heart J. 2017 May 14;38(19):1443-1446. doi: 10.1093/eurheartj/ehx216. PMID: 28510712.
Copy Download .nbib Format: NLM
Editorial Comment for the "Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials". Thrombocytopenia as an important complication with the use of antithrombotic agents.

European heart journal. Cardiovascular pharmacotherapy

Goto S, Goto S.
PMID: 27533961
Eur Heart J Cardiovasc Pharmacother. 2015 Jan;1(1):29-30. doi: 10.1093/ehjcvp/pvu014. Epub 2015 Jan 01.

No abstract available.

Cite
Goto S, Goto S. Editorial Comment for the "Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials". Thrombocytopenia as an important complication with the use of antithrombotic agents. Eur Heart J Cardiovasc Pharmacother. 2015;1(1):29-30doi: 10.1093/ehjcvp/pvu014.
Goto, S., & Goto, S. (2015). Editorial Comment for the "Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials". Thrombocytopenia as an important complication with the use of antithrombotic agents. European heart journal. Cardiovascular pharmacotherapy, 1(1), 29-30. https://doi.org/10.1093/ehjcvp/pvu014
Goto, Shinichi, and Goto, Shinya. "Editorial Comment for the "Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials". Thrombocytopenia as an important complication with the use of antithrombotic agents." European heart journal. Cardiovascular pharmacotherapy vol. 1,1 (2015): 29-30. doi: https://doi.org/10.1093/ehjcvp/pvu014
Goto S, Goto S. Editorial Comment for the "Risk of Thrombocytopenia with Glycoprotein IIb/IIIa Inhibitors across Drugs and Patient Populations: a Meta-Analysis of 29 Large Placebo-Controlled Randomized Trials". Thrombocytopenia as an important complication with the use of antithrombotic agents. Eur Heart J Cardiovasc Pharmacother. 2015 Jan;1(1):29-30. doi: 10.1093/ehjcvp/pvu014. Epub 2015 Jan 01. PMID: 27533961.
Copy Download .nbib Format: NLM
A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines.

European heart journal. Cardiovascular pharmacotherapy

Rosano GM, Ceconi C.
PMID: 27533973
Eur Heart J Cardiovasc Pharmacother. 2015 Apr;1(2):80-1. doi: 10.1093/ehjcvp/pvu005.

No abstract available.

Cite
Rosano GM, Ceconi C. A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines. Eur Heart J Cardiovasc Pharmacother. 2015;1(2):80-1doi: 10.1093/ehjcvp/pvu005.
Rosano, G. M., & Ceconi, C. (2015). A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines. European heart journal. Cardiovascular pharmacotherapy, 1(2), 80-1. https://doi.org/10.1093/ehjcvp/pvu005
Rosano, Giuseppe M C, and Ceconi, Claudio. "A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines." European heart journal. Cardiovascular pharmacotherapy vol. 1,2 (2015): 80-1. doi: https://doi.org/10.1093/ehjcvp/pvu005
Rosano GM, Ceconi C. A way forward to the elimination of conflict of interest for experts involved in regulatory medicine and guidelines. Eur Heart J Cardiovasc Pharmacother. 2015 Apr;1(2):80-1. doi: 10.1093/ehjcvp/pvu005. PMID: 27533973.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 5188 entries